To underscore the therapeutic potential of TASK modulation, Sormann et al99 identified in a human genomic analysis 9 probands with de novo gain-of-function mutations in TASK-1, all of whom had sleep apnea alongside developmental abnormalities. The gene discussed is KCNK3; the disease is sleep apnea syndrome.